Niraxostat
CAS No. 206884-98-2
Niraxostat( Y 700 | Y-700 | Y700 )
Catalog No. M28003 CAS No. 206884-98-2
Niraxostat is one of the isocytosine derivatives as xanthine oxidase inhibitors.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 284 | Get Quote |
|
| 10MG | 444 | Get Quote |
|
| 25MG | 709 | Get Quote |
|
| 50MG | 1008 | Get Quote |
|
| 100MG | 1341 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameNiraxostat
-
NoteResearch use only, not for human use.
-
Brief DescriptionNiraxostat is one of the isocytosine derivatives as xanthine oxidase inhibitors.
-
DescriptionNiraxostat is one of the isocytosine derivatives as xanthine oxidase inhibitors.
-
In Vitro——
-
In Vivo——
-
SynonymsY 700 | Y-700 | Y700
-
PathwayMetabolic Enzyme/Protease
-
TargetXanthine Oxidase (XAO)
-
RecptorLigand for E3 Ligase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number206884-98-2
-
Formula Weight299.33
-
Molecular FormulaC16H17N3O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC(C)(C)COc1ccc(cc1C#N)-n1cc(cn1)C(O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Andrew P. Crew, et al. Imide-based modulators of proteolysis and associated methods of use. US20160058872A1.
molnova catalog
related products
-
Benzbromarone
A uricosuric agent and non-competitive inhibitor of xanthine oxidase (Ki=8.5 uM); also has potentcy for CYP2C9; also blocks calcium-activated chloride channel (CaCC) TMEM16A with IC50 of 9.97 uM in HEK293 cells.
-
Prudomestin
Prudomestin is a natural product isolated from the heartwood of Prunus domestica, with xanthine oxidase (XO) inhibitory activity with IC50 of 6?μM.
-
Xanthine oxidoreduct...
Xanthine oxidoreductase-IN-4 is an orally active xanthine oxidoreductase (XOR) inhibitor with an IC50 value of 29.3 nM, useful for studying hyperuricemia.
Cart
sales@molnova.com